Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Does pathological stage affect the prognosis for patients with clinically staged T1 renal cell carcinoma?

Nature Clinical Practice Urology volume 2, pages 212–213 (2005)Cite this article

boxed-textRoberts WW et al. (2005) Pathological stage does not alter the prognosis for renal lesions determined to be stage T1 by computerized tomography. J Urol 173: 713–715

Background

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

References

  1. Zisman A et al. (2001) Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol 19: 1649–1657

    Article  CAS  Google Scholar 

  2. Frank I et al. (2002) An outcome prediction model for patients with clear cell renal cell carcinoma treated with radical nephrectomy based on tumor stage, size, grade and necrosis: the SSIGN score. J Urol 168: 2395–2400

    Article  Google Scholar 

  3. Han KR et al. (2003) TNM T3a renal cell carcinoma: adrenal gland involvement is not the same as renal fat invasion. J Urol 169: 899–903

    Article  Google Scholar 

  4. Siemer S et al. (2005) Current TNM classification of renal cell carcinoma evaluated: revising stage T3a. J Urol 173: 33–37

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Sandra Michelmore, Asssociate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

  1. Associate Professor in Urology and Director of Research, Urologic Oncology, at Fox Chase Cancer Center, Temple University, Philadelphia, PA, USA

    Robert G Uzzo

Authors
  1. Robert G Uzzo
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Robert G Uzzo.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Glossary

FUHRMAN NUCLEAR GRADE

Nuclear grading system ranging from I (best prognosis) to IV (worst prognosis)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Uzzo, R. Does pathological stage affect the prognosis for patients with clinically staged T1 renal cell carcinoma?. Nat Rev Urol 2, 212–213 (2005). https://doi.org/10.1038/ncpuro0182

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0182

Search

Advanced search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing